Cidara

$2.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.93%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Cidara and other stocks, options, ETFs, and crypto commission-free!

About CDTX

Cidara Therapeutics, Inc. Common Stock, also called Cidara, is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Read More Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Employees
68
Headquarters
San Diego, California
Founded
2012
Market Cap
57.02M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.44M
High Today
$2.17
Low Today
$2.11
Open Price
$2.14
Volume
119.31K
52 Week High
$4.95
52 Week Low
$1.22

Collections

CDTX Earnings

-$0.80
-$0.68
-$0.56
-$0.44
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.